{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T05:25:12Z","timestamp":1703654712937},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z. Rheumatol."],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s00393-013-1344-1","type":"journal-article","created":{"date-parts":[[2014,6,12]],"date-time":"2014-06-12T08:14:23Z","timestamp":1402560863000},"page":"408-414","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Polymyalgia rheumatica in der t\u00e4glichen Praxis"],"prefix":"10.1007","volume":"73","author":[{"given":"M.","family":"Talke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.A.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,6,14]]},"reference":[{"key":"1344_CR1","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1136\/bmj.2.1450.811","volume":"2","author":"Bruce","year":"1888","unstructured":"Bruce W (1888) Senile rheumatologic gout. Br Med J 2:811\u2013813","journal-title":"Br Med J"},{"key":"1344_CR2","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1136\/ard.16.2.230","volume":"16","author":"Barber","year":"1957","unstructured":"Barber HS (1957) Myalgic syndrome with constitutional effects: polymyalgia rheumatica. Ann Rheum Dis 16:230\u2013237","journal-title":"Ann Rheum Dis"},{"key":"1344_CR3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.berh.2012.01.007","volume":"26","author":"Soriano","year":"2012","unstructured":"Soriano A, Landolfi R, Manna R (2012) Polymyalgia rheumatica in 2011. Best Pract Res Clin Rheumatol 26:91\u2013104","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"1344_CR4","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ejim.2013.03.003","volume":"24","author":"Pipitone","year":"2013","unstructured":"Pipitone N, Salvarani C (2013) Update on Polymyalgia rheumatica. Eur J Intern Med 24:583\u2013589","journal-title":"Eur J Intern Med"},{"key":"1344_CR5","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00393-012-1103-8","volume":"72","author":"Schmidt","year":"2013","unstructured":"Schmidt WA (2013) Polymyalgia rheumatica. Z Rheumatol 72:59\u201365","journal-title":"Z Rheumatol"},{"key":"1344_CR6","doi-asserted-by":"crossref","first-page":"S1128","DOI":"10.3949\/ccjm.69.Suppl_2.SII28","volume":"69","author":"Weyand","year":"2002","unstructured":"Weyand CM et al (2002) Pathogenic mechanism in giant cell arteriitis. Cleve J Clin Med 69(Suppl 2):S1128\u2013S1128","journal-title":"Cleve J Clin Med"},{"key":"1344_CR7","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/ard.38.5.434","volume":"38","author":"Bird","year":"1979","unstructured":"Bird HA, Esselinckx W, Dixon AS et al (1979) An evaluation of criteria for polymyalgia rheumatic. Ann Rheum Dis 38:434\u2013439","journal-title":"Ann Rheum Dis"},{"key":"1344_CR8","doi-asserted-by":"crossref","first-page":"672","DOI":"10.7326\/0003-4819-97-5-672","volume":"97","author":"Chuang","year":"1982","unstructured":"Chuang TY, Hunder GG, Ilstrup DM et al (1982) Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med 97:672\u2013680","journal-title":"Ann Intern Med"},{"key":"1344_CR9","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/0049-0172(84)90012-X","volume":"13","author":"Healey","year":"1984","unstructured":"Healey LA (1984) Long\u2010term follow\u2010up of polymyalgia rheumatica: evidence for synovitis. Semin Arthritis Rheum 13:322\u2013328","journal-title":"Semin Arthritis Rheum"},{"key":"1344_CR10","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1136\/annrheumdis-2011-200329","volume":"71","author":"Dasgupta","year":"2012","unstructured":"Dasgupta B, Cimmino MA, Maradit-Kremers H et al (2012) 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative. Ann Rheum Dis 71:484\u2013492","journal-title":"Ann Rheum Dis"},{"key":"1344_CR11","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00393-012-1070-0","volume":"71","author":"Schmidt","year":"2012","unstructured":"Schmidt WA (2012) Neue Klassifikationskriterien der Polymyalgia rheumatica. Z Rheumatol 71:911\u2013912","journal-title":"Z Rheumatol"},{"key":"1344_CR12","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3899\/jrheum.110977","volume":"39","author":"Matteson","year":"2012","unstructured":"Matteson EL, Maradit-Kremers H, Cimmino MA et al (2012) Patient-reported outcomes in polymyalgia rheumatica. J Rheumatol 39:795\u2013803","journal-title":"J Rheumatol"},{"key":"1344_CR13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1056\/NEJMra011913","volume":"347","author":"Salvarani","year":"2002","unstructured":"Salvarani C, Cantini F, Boiardi L et al (2002) Polymyalgia rheumatica and giant cell arteritis. N Engl J Med 347:261\u2013271","journal-title":"N Engl J Med"},{"key":"1344_CR14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1053\/sarh.2000.8366","volume":"30","author":"Cantini","year":"2000","unstructured":"Cantini F, Salvarani C, Olivieri I et al (2000) Erythrocyte sedimentation rate and C-reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: a prospective follow-up study. Semin Arthritis Rheum 30:17\u201324","journal-title":"Semin Arthritis Rheum"},{"key":"1344_CR15","doi-asserted-by":"crossref","unstructured":"Blockmans D, De Ceuninck L, Vanderschueren S et al (2007) Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a prospective study in 35 patients. Rheumatology (Oxford) 46:672\u2013677","DOI":"10.1093\/rheumatology\/kel376"},{"key":"1344_CR16","first-page":"462","volume":"23","author":"Cantini","year":"2005","unstructured":"Cantini F, Niccoli L, Nannini C et al (2005) Inflammatory changes of hip synovial structures in polymyalgia rheumatica. Clin Exp Rheumatol 23:462\u2013468","journal-title":"Clin Exp Rheumatol"},{"key":"1344_CR17","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1136\/ard.2007.084723","volume":"67","author":"Salvarani","year":"2008","unstructured":"Salvarani C, Barozzi L, Cantini F et al (2008) Cervical interspinous bursitis in active polymyalgia rheumatica. Ann Rheum Dis 67:758\u2013761","journal-title":"Ann Rheum Dis"},{"key":"1344_CR18","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1136\/annrheumdis-2013-204167","volume":"73","author":"Macchioni","year":"2014","unstructured":"Macchioni P, Boiardi L, Catanoso M et al (2014) Performance of the new 2012 EULAR\/ACR classification criteria for polymyalgia rheumatica: comparison with the previous criteria in a single-centre study. Ann Rheum Dis 73:1190\u20131193","journal-title":"Ann Rheum Dis"},{"key":"1344_CR19","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.berh.2013.01.001","volume":"27","author":"Schmidt","year":"2013","unstructured":"Schmidt WA (2013) Imaging in vasculitis. Best Pract Res Clin Rheumatol 27:107\u2013118","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"1344_CR20","unstructured":"Schmidt WA, Gromnica-Ihle E (2011) Polymyalgia rheumatica und Riesenzellarteriitis (Arteriitis temporalis). In: Busse O, Fleig WE, Mayet WJ et al (Hrsg) Rationelle Diagnostik und Therapie in der Inneren Medizin: Leitlinien-basierte Empfehlungen f\u00fcr die Praxis. Elsevier, M\u00fcnchen"},{"key":"1344_CR21","first-page":"S704","volume":"65","author":"Cimmino","year":"2013","unstructured":"Cimmino MA, Dasgupta B, Crowson C et al (2013) Obese polymyalgia rheumatica patients experience more pain and disability and need higher doses of glucocorticoids. Arthritis Rheum 65(Suppl):S704","journal-title":"Arthritis Rheum"},{"key":"1344_CR22","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1002\/art.22754","volume":"56","author":"Mahr","year":"2007","unstructured":"Mahr AD, Jover JA, Spiera RF et al (2007) Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis. Arthritis Rheum 56:2789\u20132797","journal-title":"Arthritis Rheum"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-013-1344-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-013-1344-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-013-1344-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T16:36:18Z","timestamp":1559061378000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-013-1344-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["1344"],"URL":"https:\/\/doi.org\/10.1007\/s00393-013-1344-1","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}